Burling Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Burling Wealth Partners's MRK Position: Q3 2026 in Review
Burling Wealth Partners reduced its Merck (MRK) stake by 0.17% in Q3 2026, selling an estimated $6.08K and leaving 26,200 shares worth $3.81M. The position accounts for 0.54% of the portfolio, ranked #43.
Burling Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.61M in Q4 2024. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Burling Wealth Partners held 26,200 shares of Merck worth $3.81M as of Q3 2026.
- Burling Wealth Partners sold 44 Merck shares in Q3 2026, an estimated $6.08K.
- Merck made up 0.54% of Burling Wealth Partners's portfolio in Q3 2026, its #43 holding.
- Burling Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
- Burling Wealth Partners's Merck position peaked at $5.61M in Q4 2024.
- 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Burling Wealth Partners's 13F filing for Q3 2026, filed 9 Nov 2026.